In order to speed up drug procurement, CGHS has directed pharmaceutical manufacturers and authorized importers to submit regulatory and production filings for oncology, diabetes, spinal muscular atrophy therapy and bispecific antibody drugs.
In order to speed up drug procurement, CGHS has directed pharmaceutical manufacturers and authorized importers to submit regulatory and production filings for oncology, diabetes, spinal muscular atrophy therapy and bispecific antibody drugs.
<iframe src="https://hindustansphere.com/embed/cluster/c1e48dc8492e399619589727ec27d007d0f448de" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="CGHS maps domestic manufacturing capacity for 153 critical drugs to shorten supply delays"></iframe>
In order to speed up drug procurement, CGHS has directed pharmaceutical manufacturers and authorized importers to submit regulatory and production filings for oncology, diabetes, spinal muscular atrophy therapy and bispecific antibody drugs.
